Major histocompatibility complex class II antigen presentation in Hodgkin's disease

Leukemia and Lymphoma

Volumn 36, Issue 1-2, 1999, Pages 9-14

  Bosshart, Herbert ^a  

^a BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Class II antigen; Hodgkin's disease; Major histocompatibility complex

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; CANCER CELL; CONTROLLED STUDY; HODGKIN DISEASE; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; REED STERNBERG CELL; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0033462125     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909145944     Document Type: Review

References (22)

1. Kuppers, R. and Rajewsky, K. (1998) The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease. Annu Rev Immunol, 16, 471-493.
2. Poppema, S., Bhan, A.K., Reinherz, E.L., Posner, M.R. and Schlossman, S.F. (1982) In situ immunologic characterization of cellular constituents in lymph nodes and spleens involved by Hodgkin's disease. Blood, 59, 226-232.
3. Bosshart, H. and Jarrett, R.F. (1998) Deficient major histocompatibility complex class II antigen presentation in a subset of Hodgkin's disease tumor cells. Blood, 92, 2252-2259.
4. Gruss, H.J., Pinto, A., Duyster, J., Poppema, S. and Herrmann, F. (1997) Hodgkin's disease: a tumor with disturbed immunological pathways. Immunol Today, 18, 156-163.
5. Margulies, D.H. (1997) Interactions of TCRs with MHC-peptide complexes: a quantitative basis for mechanistic models. Curr Opin Immunol, 9, 390-395.
6. Mellman, I., Turley, S.J. and Steinman, R.M. (1998) Antigen processing for amateurs and professionals. Trends Cell Biol, 8, 231-237.
7. Schwartz, R. H. (1992) Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB in interleukin-2 production and immunotherapy. Cell, 71, 1065-1068.
8. Allison, J. P. and Krummel, M. F. (1995) The Yin and Yang of T cell costimulation. Science, 270, 932-933.
9. Van Gool, S.W., Delabie, J., Vandenberghe, P., Coorevits, I., De Wolf-Peeters, C and Ceuppens, J.L. (1997) Expression of B7-2 (CD86) molecules by Reed-Sternberg cells of Hodgkin's disease. Leukemia, 11, 846-851.
10. Bosshart, H and Jarrett, R.F. (1998) Presentation of major histocompatibility complex class II self peptides by tumor cells of Hodgkin's disease. Leukemia and Lymphoma, 29, P-41.
11. Weber, D.A., Evavold, B.D. and Jensen, P.E. (1996) Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science, 274, 618-620.
12. Cresswell, P. (1996) Invariant chain structure and MHC class II function. Cell, 84, 505-507.
13. Denzin, L.K., Robbins, N.F., Carboy-Newcomb, C. and Cresswell, P. (1994) Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity, 1, 595-606.
14. + T-cell responses. Immunol Today, 17, 410-414.
15. Roy, M., Aruffo, A., Ledbetter, J., Linsley, P., Kehry, M. and Noelle, R. (1995) Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur J Immunol, 25, 596-603.
16. Lenschow, D.J., Walunas, T.L. and Bluestone, J.A. (1996) CD28/B7 system of T cell costimulation. Anna Rev Immunol, 14, 233-258.
17. Farr, A., DeRoos, P.C., Eastman, S. and Rudensky, A.Y. (1996) Differential expression of CLIP:MHC class II and conventional endogenous peptide:MHC class II complexes by thymic epithelial cells and peripheral antigen-presenting cells. Eur. J Immunol, 26, 3185-3193.
18. Herbst, H., Dallenbach, F., Hummel, M., Niedobitek, G., Pileri, S., Muller-Lantzsch, N. and Stein, H. (1991) Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci USA, 88, 4766-4770.
19. Gruss, H.J., Hirschstein, D., Wright, B., Ulrich, D., Caligiuri, M.A., Barcos, M., Strockbine, L., Armitage, R.J., and Dower, S.K. (1994) Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease. Blood, 84, 2305-2314.
20. Viola A. and Lanzavecchia A. (1996) T cell activation determined by T cell receptor number and tunable thresholds. Science, 273, 104-106.
21. Fisher, R.I., Bostick-Bruton, F., Sauder, D.N., Scala, G. and Diehl, V. (1983) Neoplastic cells obtained rom Hodgkin's disease are potent stimulators of human primary mixed lymphocyte cultures. J Immunol. 130, 2666-2670.
22. Chicz, R.M., Urban, R.G., Gorga, J.C., Vignali, D.A.A., Lane, W.S. and Strominger, J.L. (1993) Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med. 178, 27-47.